CLINICAL TRIAL / NCT05886764

Inclusion Criteria for Patient Subjects: - Aged 18 years or older - Self-described African American race (patients who self-describe as "more than one race" will be included) - Scheduled for new or consult oncology appointment at the study site - Scheduled for return outpatient oncology appointment at the study site with a biopsy or radiology encounter within 2 weeks prior to provider visit. - for prostate cancer patients: 2 or more increasing prostate specific antigen (PSA) values i the 6 months prior to visit - other patient identified by research team as potentially having a change in treatment prior to next outpatient oncology appointment at the study site Inclusion Criteria for Provider Subjects: - oncology provider at study site scheduled to see patients meeting criteria above Exclusion Criteria for Patient Subjects: - Estimated glomerular filtration rate (GFR) less than 30 ml/min/1.73m2 documented within last 2 months and without documented resolutions - Bilirubin greater than 3.0 ng/dl documented within last 2 months and without documented resolution - Initiated new anti-cancer therapy within last 2 months - Evaluated for possible enrollment/randomization in the last 2 months - Prior enrollment/randomization on this recruitment trial